Table 1 Demographics, specific IgE and symptom scores in placebo and active treated group
Parameter Median (Min, Max) | Placebo, n = 10 | Active, n = 31 | t test |
|---|---|---|---|
 Age, y | 31.4 (20.5–34.6) | 24.7 (20.2–53.4) | 0.859 |
 women/men | 4/6 | 18/12 |  |
Before SLIT | |||
 Der f - IgE, kUA/l | 17.1 (2.8,67.9) | 14.3 (0.9, > 100) | 0.574 |
 TNSS | 6.8 (5.1, 10.3) | 7.1 (3.8, 11.8) | 0.5213 |
After SLIT | |||
 Der f - IgE, kUA/l | 22.9 (2.2, 45.8) | 25.8 (1.3, > 100) | 0.096 |
 TNSS | 7.7 (4.1,12) | 4.1 (0.5, −10.6) | 0.0023 |
Absolute change (after-before) | |||
 Der f - IgE, kUA/l | 0.4 (−40.3, 11.8) | 9.1 (−14.5, 84.3) | 0.007 |
 TNSS | -1 (−2.3, 4.1) | 4 (−3.2, 8.5) | 0.0021 |